{"id":1332,"date":"2010-10-06T10:06:22","date_gmt":"2010-10-06T14:06:22","guid":{"rendered":"http:\/\/sciencebusiness.technewslit.com\/?p=1332"},"modified":"2010-10-06T10:06:22","modified_gmt":"2010-10-06T14:06:22","slug":"anxietydepression-drug-trials-approved-in-france","status":"publish","type":"post","link":"https:\/\/technewslit.com\/sciencebusiness\/?p=1332","title":{"rendered":"Anxiety\/Depression Drug Trials Approved in France"},"content":{"rendered":"<figure id=\"attachment_1334\" aria-describedby=\"caption-attachment-1334\" style=\"width: 200px\" class=\"wp-caption alignleft\"><a href=\"http:\/\/technewslit.com\/sciencebusiness\/wp-content\/uploads\/2010\/10\/Brain_NIH.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-1334\" title=\"Brain_NIH\" src=\"http:\/\/technewslit.com\/sciencebusiness\/wp-content\/uploads\/2010\/10\/Brain_NIH.jpg\" alt=\"Illustration of brain (NIDA)\" width=\"200\" height=\"199\" srcset=\"https:\/\/technewslit.com\/sciencebusiness\/wp-content\/uploads\/2010\/10\/Brain_NIH.jpg 200w, https:\/\/technewslit.com\/sciencebusiness\/wp-content\/uploads\/2010\/10\/Brain_NIH-150x149.jpg 150w\" sizes=\"auto, (max-width: 200px) 100vw, 200px\" \/><\/a><figcaption id=\"caption-attachment-1334\" class=\"wp-caption-text\">(National Institute of Drug Abuse)<\/figcaption><\/figure>\n<p>Bionomics Limited, a drug development company in Adelaide, Australia, says the French national medical agency and ethics committee for Strasburg Hospital have approved the company&#8217;s request to conduct <a href=\"http:\/\/www.bionomics.com.au\/page.php?section=140&amp;item=407\">clinical trials for BNC210<\/a>, Bionomics&#8217; treatment of anxiety and depression now in development.<\/p>\n<p>The first clinical study will examine whether BNC210 reduces panic and anxiety symptoms induced by pharmacological means in healthy volunteers. The company says it will use the peptide CCK-4 to induce symptoms of panic and anxiety. Bionomics has previously reported that BNC210, in a rodent model of CCK induced anxiety, overcomes the effects of CCK.<\/p>\n<p>The second trial, says Bionomics, will evaluate BNC210&#8217;s effects on the brain using electro-encephalograph and quantitative assessments of memory function. In this trial the effects of BNC210 will be compared with Lorazepam, a drug closely related to Valium, which is known to have the adverse side effect of causing memory impairment.<\/p>\n<p>Bionomics&#8217; subsidiary, Neurofit SAS, is the designated sponsor of the trials. Both trials will be conducted in parallel in France by Forenap Pharma, a contract research organization. Data from the trials are expected to be available in the first quarter of 2011.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Bionomics Limited, a drug development company in Adelaide, Australia, says the French national medical agency and ethics committee for Strasburg Hospital have approved the company&#8217;s request to conduct clinical trials for BNC210, Bionomics&#8217; treatment of anxiety and depression now in development. The first clinical study will examine whether BNC210 reduces panic and anxiety symptoms induced [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[15,5],"tags":[28,45,27],"class_list":["post-1332","post","type-post","status-publish","format-standard","hentry","category-products","category-regulations","tag-clinical-trials","tag-europe","tag-pharmaceuticals"],"_links":{"self":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts\/1332","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1332"}],"version-history":[{"count":2,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts\/1332\/revisions"}],"predecessor-version":[{"id":1335,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts\/1332\/revisions\/1335"}],"wp:attachment":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1332"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1332"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1332"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}